MTOR and urinary bladder carcinoma: Yu et al.31reported that the phosphatidylinositol 3‐kinas (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway can be promoted by STIL, which can raise c‐myc expression and ultimately encourage the occurrence and development of bladder cancer.